Sign in

CIK 0001570562

  • Accelerated filer

Evolus, Inc.

Sign in to watch
Ticker
EOLS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
461385614
Phone
+1 949-284-4555
Business address
520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH, CA, 92660
Former names
Evolus, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$950,019
in 1 filing

Net −$950,019. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. MOATAZEDI DAVID −$950K Reporting owner sold 17% of stake
Date Insider Transaction Shares Price Value Owned after
2024-02-07 HAYMAN ROBERT Director Grant or award +6,464 54,856
2024-02-07 HAYMAN ROBERT Director Grant or award · Stock Option (Right to Buy) +9,377 9,377
2023-08-11 HAYMAN ROBERT Director Other acquisition +218 48,392
2023-08-11 HAYMAN ROBERT Director Other acquisition +366 10,366
2023-01-27 HAYMAN ROBERT Director Grant or award +8,293 48,174
2023-01-27 HAYMAN ROBERT Director Grant or award · Stock Option (Right to Buy) +11,789 11,789
2022-09-12 HAYMAN ROBERT Director Purchase +1,091 $10.78 $12K 10,000
2022-09-09 HAYMAN ROBERT Director Purchase +8,909 $10.35 $92K 8,909
2022-09-07 HAYMAN ROBERT Director Purchase +5,000 $10.05 $50K 39,881
2022-09-07 HAYMAN ROBERT Director Purchase +4,967 $10.05 $50K 39,848
2022-01-24 HAYMAN ROBERT Director Grant or award +15,568 34,881
2022-01-24 HAYMAN ROBERT Director Grant or award · Stock Option (Right to Buy) +22,727 22,727
2021-02-05 HAYMAN ROBERT Director Grant or award +19,313 19,313
2020-01-23 HAYMAN ROBERT Director Grant or award · Stock Option (Right to Buy) +23,458 23,458
2019-01-23 HAYMAN ROBERT Director Grant or award · Stock Option (Right to Buy) +14,500 14,500
2018-04-24 HAYMAN ROBERT Director Grant or award · Stock Option (Right to Buy) +9,086 9,086

Page 1 of 1 · 16 trades